Work

Alternatives to Government-Imposed Price Controls to Lower US Drug Prices

Year: 2025

Type: article

Abstract: This JAMA Forum discusses the limits of most-favored-nation pricing and other price controls on US drugs and provides policy alternatives, including generic and biosimilar competition, value-based pricing, and reforms to pharmacy benefit managers.

Source: JAMA Health Forum

DOI: 10.1001/jamahealthforum.2025.5744

Author: Lanhee J. Chen

Institutions: Hoover Institution, Stanford University

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,000